Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Howden Joinery H1 profits, revenue rise despite challenging market

(Sharecast News) - Howden Joinery posted a jump in first-half profit and revenue on Thursday as it continued to gain market share despite a challenging market. First-half pre-tax profit rose 4.4% to £117.2m on sales of £997.6m, up 3.2% on the same period a year earlier.

The interim dividend per share was lifted 2% to 5p.

Howdens highlighted continued market share gains, aided by its £11m investment in strategic initiatives.

The company - which supplies kitchens and joinery products - said there was a strong close to the period in the first half, "reflecting well executed promotions and sales incentives".

Howdens said its performance since the start of the second half has been in line with its expectations and results are second-half weighted, given the autumn peak trading period.

Chief executive Andrew Livingston said: "Howdens performed well in the first half, gaining further market share. The ongoing investment in our strategic initiatives is strengthening our competitive position, and our current trading performance gives us confidence in achieving our full year plans.

"We are well prepared for the second half, which includes our seasonally important peak trading period. This includes Howdens' best-ever line-up for kitchens, available for 2025 in more colours, styles, and finishes to suit all budgets.

"While market conditions remain challenging, our trade customers are highly skilled at winning work in such times backed by Howdens' well-incentivised depot teams, unrivalled product quality and industry leading stock availability."

At 0915 BST, the shares were up 10.5% at 924.00p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.